Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
---|
CEO | Mr. Rafael Padilla |
IPO Date | Oct. 5, 2007 |
Location | Belgium |
Headquarters | Venecoweg 20A |
Employees | 3,647 |
Sector | Health Care |
Industries |
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Past 5 years
USD 33.74
USD 673.61
USD 8.29
USD 19.81
StockViz Staff
January 15, 2025
Any question? Send us an email